Home

John T Curnutte

CIK 1574589 · EVP R&D · last filed 2026-06-12

John T Curnutte is an EVP R&D who has filed 42 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for PLRX, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$7.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLRX Director — $1.07 — $0 6 2026-06-12
Orchard Therapeutics plc (ORTX) Delisted Director — $16.70 — $0 5 2024-01-24
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted EVP R&D 102,559 — — -$7.83M 30 2019-05-21

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 PLRX Grant (A) — $0 EDGAR
2025-06-09 PLRX Grant (A) — $0 EDGAR
2024-06-17 PLRX Grant (A) — $0 EDGAR
2024-01-24 Orchard Therapeutics plc (ORTX) Delisted Disp (D) — $0 EDGAR
2023-06-16 Orchard Therapeutics plc (ORTX) Delisted Grant (A) — $0 EDGAR
2023-06-08 PLRX Grant (A) — $0 EDGAR
2022-06-21 PLRX Grant (A) — $0 EDGAR
2022-06-08 Orchard Therapeutics plc (ORTX) Delisted Grant (A) — $0 EDGAR
2021-06-30 PLRX Grant (A) — $0 EDGAR
2021-06-17 Orchard Therapeutics plc (ORTX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.